BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34259093)

  • 1. Synergic fabrication of pembrolizumab loaded doxorubicin incorporating microbubbles delivery for ultrasound contrast agents mediated anti-proliferation and apoptosis.
    Liu H; Li X; Chen Z; Bai L; Wang Y; Lv W
    Drug Deliv; 2021 Dec; 28(1):1466-1477. PubMed ID: 34259093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma.
    Zhou S; Zhang X; Wang C
    Oncotarget; 2017 Jan; 8(3):4760-4772. PubMed ID: 27902473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.
    Zhou S; Wu D; Yin X; Jin X; Zhang X; Zheng S; Wang C; Liu Y
    J Exp Clin Cancer Res; 2017 Feb; 36(1):24. PubMed ID: 28166836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
    Rapoport N; Gao Z; Kennedy A
    J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab-conjugated and doxorubicin-loaded microbubbles combined with ultrasound irradiation inhibits proliferation and induces apoptosis in Raji cell lines.
    Zhou S; Zheng S; Shan Y; Li L; Zhang X; Wang C
    Oncol Rep; 2016 Feb; 35(2):801-8. PubMed ID: 26718487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
    Tinkov S; Winter G; Coester C; Bekeredjian R
    J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid/PLGA Hybrid Microbubbles as a Versatile Platform for Noninvasive Image-Guided Targeted Drug Delivery.
    Chen Y; Liang Y; Jiang P; Li F; Yu B; Yan F
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):41842-41852. PubMed ID: 31633326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates.
    Lidický O; Janoušková O; Strohalm J; Alam M; Klener P; Etrych T
    Molecules; 2015 Nov; 20(11):19849-64. PubMed ID: 26556320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells.
    Jiang S; Wang X; Zhang Z; Sun L; Pu Y; Yao H; Li J; Liu Y; Zhang Y; Zhang W
    Int J Nanomedicine; 2016; 11():5505-5518. PubMed ID: 27843311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates.
    Law CL; Cerveny CG; Gordon KA; Klussman K; Mixan BJ; Chace DF; Meyer DL; Doronina SO; Siegall CB; Francisco JA; Senter PD; Wahl AF
    Clin Cancer Res; 2004 Dec; 10(23):7842-51. PubMed ID: 15585616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Targeting and Ultrasound Activation of Liposome-Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies.
    Dwivedi P; Kiran S; Han S; Dwivedi M; Khatik R; Fan R; Mangrio FA; Du K; Zhu Z; Yang C; Huang F; Ejaz A; Han R; Si T; Xu RX
    ACS Appl Mater Interfaces; 2020 May; 12(21):23737-23751. PubMed ID: 32374147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion-guided sonopermeation of neuroblastoma: a novel strategy for monitoring and predicting liposomal doxorubicin uptake
    Bellary A; Villarreal A; Eslami R; Undseth QJ; Lec B; Defnet AM; Bagrodia N; Kandel JJ; Borden MA; Shaikh S; Chopra R; Laetsch TW; Delaney LJ; Shaw CM; Eisenbrey JR; Hernandez SL; Sirsi SR
    Theranostics; 2020; 10(18):8143-8161. PubMed ID: 32724463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of doxorubicin-loaded poly (ε-caprolactone)-b-poly (N-vinylpyrrolidone) micelles enhances antitumor effect in lymphoma.
    Hira SK; Mishra AK; Ray B; Manna PP
    PLoS One; 2014; 9(4):e94309. PubMed ID: 24714166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted microbubbles with ultrasound irradiation and PD-1 inhibitor to increase antitumor activity in B-cell lymphoma.
    Zheng S; Song D; Jin X; Zhang H; Aldarouish M; Chen Y; Wang C
    Nanomedicine (Lond); 2018 Feb; 13(3):297-311. PubMed ID: 29338562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1-targeted microbubbles loaded with docetaxel produce a synergistic effect for the treatment of lung cancer under ultrasound irradiation.
    Li T; Hu Z; Wang C; Yang J; Zeng C; Fan R; Guo J
    Biomater Sci; 2020 Mar; 8(5):1418-1430. PubMed ID: 31942578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice.
    Mondal L; Mukherjee B; Das K; Bhattacharya S; Dutta D; Chakraborty S; Pal MM; Gaonkar RH; Debnath MC
    Int J Nanomedicine; 2019; 14():8073-8094. PubMed ID: 31632019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone.
    Sun G; Sun K; Sun J
    Drug Deliv; 2021 Dec; 28(1):1132-1140. PubMed ID: 34121558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.
    Luo W; Wen G; Yang L; Tang J; Wang J; Wang J; Zhang S; Zhang L; Ma F; Xiao L; Wang Y; Li Y
    Theranostics; 2017; 7(2):452-465. PubMed ID: 28255342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.
    Alli S; Figueiredo CA; Golbourn B; Sabha N; Wu MY; Bondoc A; Luck A; Coluccia D; Maslink C; Smith C; Wurdak H; Hynynen K; O'Reilly M; Rutka JT
    J Control Release; 2018 Jul; 281():29-41. PubMed ID: 29753957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.